Recombinant Human TRPV1 Protein，His

Transient Receptor Potential Vanilloid 1 (TRPV1) is a pivotal ion channel involved in nociception, the process by which sensory neurons respond to harmful stimuli, including heat and inflammatory pain. Discovered in the late 1990s, TRPV1 is activated by a variety of endogenous and exogenous ligands, such as capsaicin, the active component in chili peppers, and noxious heat. Research has revealed its critical role not only in pain perception but also in a range of physiological functions, such as thermoregulation and the modulation of inflammation. Given its significant involvement in pain pathways, TRPV1 has emerged as a promising target for the development of novel analgesics. The recombinant expression of TRPV1 protein in various systems, such as bacteria, yeast, or mammalian cells, allows for detailed structural and functional studies. These investigations seek to elucidate the channel’s activation mechanisms, ligand interactions, and pharmacological profiles. Furthermore, the structural insights gained from crystallography and cryo-electron microscopy of TRPV1 can be instrumental in designing selective small-molecule inhibitors that could effectively manage chronic pain without the side effects associated with conventional analgesics. Thus, the ongoing research into TRPV1 recombinant proteins not only enhances our understanding of nociceptive signaling but also opens avenues for therapeutic innovation in pain management and related disorders.